Anavex Life Sciences Corp.AVXLNASDAQ
LOADING
|||

Analyst Sentiment

Analysts lean bullish — 85% recommend buying.

Consensus Rating
Buy
13 analysts·Moderate coverage
85%
Rating Distribution
Strong Buy
00%
Buy
1185%
Hold
215%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 143% higher.

Bear Case
$11.00
+143%
Consensus
$11.00
+143%
Bull Case
$11.00
+143%
Price Range13 analysts
Low
Consensus
High
$11.00
$11.00
Current Target
Current Price
$4.52
Upside to Target
$6.48

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Dec 6, 2022Cantor Fitzgerald
Cantor Fitzgerald Downgrades Anavex Life Sciences to Neutral, Lowers Price Target to $11
Target:$11.00
+28.8%from $8.54